Active — Not RecruitingNot Applicable

Promoting Increases in Living Donation Via Tele-navigation (PILOT)

United States347 participantsStarted 2023-04-12

Plain-language summary

We hypothesize that expansion of the Living Donor Navigator (LDN) program to include tele-health delivery will overcome geographic disparities in access and facilitate sustained increases in living donation. We will utilize an individually randomized group trial (IRGT) design with delayed intervention initiation to compare the effectiveness of tele-health LDN model to standard of care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * End-stage kidney disease (ESKD) patients who are ≥ 18 years old and have initiated evaluation for kidney transplantation. * If there is an individual willing to donate, but the candidate is unwilling to consider this option or this particular individual, the candidate is eligible for the study and may still benefit from identification of new donors or increased comfort accepting donation from others. * Candidates must be English-speaking or deaf with an interpreter. Exclusion Criteria: * Individuals under the age of 18 will be excluded from the study. * Individuals who are not English speaking will be excluded from the study.

What they're measuring

Number Live Donor Screenings

Timeframe: Within 3 months of condition

Number of Live Donor Approvals

Timeframe: Within 3 months of condition

Trial details

NCT IDNCT05468463

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-30

View on ClinicalTrials.gov More Kidney Diseases trials